Insider Transactions Reported by 12 Insiders of Phio Pharmaceuticals Corp.

Symbol
PHIO on Nasdaq
Location
King Of Prussia, PA

Insiders trading volume in the past year

Phio Pharmaceuticals Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gerrit Dispersyn President & CEO, Director $320,614 01 Mar 2022
Robert J. Bitterman Chairman, Pres. & CEO, Director $300,163 +$38,711 +15% 31 Dec 2025
Lisa Cabott Carson VP, Finance and Administration $89,300 11 Sep 2025
Robert L. Ferrara Director $73,465 +$10,600 +17% 11 Sep 2025
PATRICIA A. BRADFORD Director $51,586 11 Sep 2025
Curtis Lockshin Director $35,254 11 Sep 2025
H. Paul Dorman Director $30,759 15 Feb 2022
Jonathan E. Freeman Director $30,504 11 Sep 2025
David H. Deming Director $26,600 11 Sep 2025
Caitlin Kontulis Secretary & VP Finance & Admin $10,196 01 Mar 2024
Robert M. Infarinato Vp, Cfo $8,140 11 Sep 2024
GEERT CAUWENBERGH Director $6,395 17 Feb 2023

Recent Insider Transactions by Companies or Individuals for Phio Pharmaceuticals Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.